Acetazolamide and Lopressor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetazolamide (acetazolamide) and Lopressor (metoprolol tartrate). Common drug interactions include nausea among females and blood chloride decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Acetazolamide and Lopressor. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.



On Jul, 15, 2026

15 people who take Acetazolamide and Lopressor together, and have interactions are studied.

Acetazolamide and Lopressor drug interactions.

What are the common drug interactions of Acetazolamide and Lopressor, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Vomiting
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Cardiac failure congestive
  8. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  9. Acidosis (build-up of carbon dioxide in the blood)
  10. Anaemia (lack of blood)

male:

  1. Blood chloride decreased
  2. Blood glucose increased
  3. Blood urea increased
  4. Carbon dioxide decreased
  5. Cardiac failure congestive
  6. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  7. Diabetic ulcer
  8. Pericardial effusion (fluid around the heart)
  9. Pneumonia
  10. Pulmonary oedema (fluid accumulation in the lungs)

What are the common drug interactions of Acetazolamide and Lopressor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cellulitis (infection under the skin)
  2. Diarrhoea
  3. Dry mouth
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Nausea (feeling of having an urge to vomit)

50-59:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Acute respiratory failure
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Asthma
  7. Blood glucose increased
  8. Body temperature increased
  9. Brain natriuretic peptide increased
  10. Cardiac failure congestive

60+:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Cardiac failure congestive
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Dyspnoea (difficult or laboured respiration)
  5. Gangrene (body tissue dies)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Haemodynamic instability (disturbances in the blood movement in our body)
  8. Heparin-induced thrombocytopenia
  9. Hypotension (abnormally low blood pressure)
  10. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 20.00%
  2. Heart Rate Increased: 3 people, 20.00%
  3. Serratia Sepsis (a bacterial whole body inflammation): 3 people, 20.00%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 13.33%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
  6. Agitation (state of anxiety or nervous excitement): 1 person, 6.67%
  7. Bleeding Disorders: 1 person, 6.67%
  8. Cardiac Disorder: 1 person, 6.67%
  9. Cardiac Failure: 1 person, 6.67%
  10. Diarrhea: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and Lopressor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acetazolamide and Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetazolamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopressor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide and metoprolol tartrate (the active ingredients of Acetazolamide and Lopressor, respectively), and Acetazolamide and Lopressor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: